120 related articles for article (PubMed ID: 310289)
1. [Immune profile in melanoma patients. I. PHA--stimulation of circulating lymphocytes and number of T- and B-lymphocytes (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(6):559-64. PubMed ID: 310289
[TBL] [Abstract][Full Text] [Related]
2. T and B lymphocytes in malignant melanoma patients.
Babusiková O; Novotná L; Schneková K; Turková D; Havránková M
Neoplasma; 1976; 23(6):635-44. PubMed ID: 1087378
[TBL] [Abstract][Full Text] [Related]
3. [Comparative examinations of the effect of general and local anesthesia upon the T-lymphocytes in melanoma operations (author's transl)].
Seebacher C; Bässler E
Arch Geschwulstforsch; 1981; 51(2):179-86. PubMed ID: 6973960
[TBL] [Abstract][Full Text] [Related]
4. [T-Lymphocyte shifts in patients with melanoma and bronchogenic carcinoma (author's transl)].
Pichler WJ; Stingl G; Micksche M; Neumann H; Knapp W
Wien Klin Wochenschr; 1976 Nov; 88(21):707-9. PubMed ID: 1087506
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
Serov AA; Kadagidze ZG
Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
[TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy of malignant melanoma (active specific and non-specific immune stimulation) (author's transl)].
Kokoschka EM; Micksche M
Wien Klin Wochenschr; 1976 Nov; 88(21):690-6. PubMed ID: 1007279
[TBL] [Abstract][Full Text] [Related]
7. [Variations of B- and T-lymphocytes in the peripheral blood and variations of the stimulability of cyclic nucleotides in the T-lymphocytes of patients suffering from malignant melanoma (author's transl)].
Busse E; Rose H; Lehnert W
Dermatol Monatsschr; 1979 Sep; 165(9):634-41. PubMed ID: 230989
[TBL] [Abstract][Full Text] [Related]
8. In vitro studies of axillary lymph node cells in patients with breast cancer.
Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
[TBL] [Abstract][Full Text] [Related]
9. [Immunophenotype of lymphocytes of patients with malignant melanoma and its dynamics during immunotherapy with interleukin-2].
Kadagidze ZG; Iavorskiĭ VV; Baryshnikov AIu; Solov'eva EA; Savel'eva EV; Cheremushkin EA; Korotkova OV
Vopr Onkol; 1991; 37(5):544-9. PubMed ID: 1767507
[TBL] [Abstract][Full Text] [Related]
10. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
[TBL] [Abstract][Full Text] [Related]
11. Melanoma-associated immunosuppression through B cell activation of suppressor T cells.
Ninnemann JL
J Immunol; 1978 May; 120(5):1573-9. PubMed ID: 307018
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immune response during specific hyposensitization in atopic asthma patients.
Moniuszko T; Chyrek-Borowska S; Moniuszko C
Arch Immunol Ther Exp (Warsz); 1984; 32(4):375-80. PubMed ID: 6335958
[TBL] [Abstract][Full Text] [Related]
13. [Possibilities of differentiated stimulation of B- and T-cells (author's transl)].
Schwenke H; von Baehr R
Allerg Immunol (Leipz); 1978; 24(2):108-17. PubMed ID: 150781
[TBL] [Abstract][Full Text] [Related]
14. [Rosette forming B- and T-lymphocytes in allergic contact eczema (author's transl)].
Hofmann C; Rytter M; Haustein UF
Allerg Immunol (Leipz); 1981; 27(1):53-7. PubMed ID: 6455058
[TBL] [Abstract][Full Text] [Related]
15. In vitro lymphocyte reactivity and T cell levels in patients with melanoma: correlations with clinical and pathological stage.
Silverman NA; Alexander JC; Potvin C; Chretien PB
Surgery; 1976 Mar; 79(3):332-9. PubMed ID: 1083075
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
[TBL] [Abstract][Full Text] [Related]
17. Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma.
Bernengo MG; Lisa F; Meregalli M; Doveil GC
Int J Tissue React; 1984; 6(6):505-11. PubMed ID: 6335712
[TBL] [Abstract][Full Text] [Related]
18. PHA stimulation of separated human lymphocyte populations.
Potter MR; Moore M
Clin Exp Immunol; 1975 Sep; 21(3):456-67. PubMed ID: 1106926
[TBL] [Abstract][Full Text] [Related]
19. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
[TBL] [Abstract][Full Text] [Related]
20. Change in the proportion of T and B lymphocytes in human malignant neoplasia in relation to the clinical stage.
Babusíková O; L' Novotná ; Korec S; Schneková K; Turková D; Havránková M; Plentová K
Neoplasma; 1975; 22(4):413-21. PubMed ID: 1081657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
